128 related articles for article (PubMed ID: 725852)
1. Thromboxane generation and platelet aggregation in survivals of myocardial infarction.
Szczeklik A; Gryglewski RJ; Musiał J; Grodzińska L; Serwońska M; Marcinkiewicz E
Thromb Haemost; 1978 Aug; 40(1):66-74. PubMed ID: 725852
[TBL] [Abstract][Full Text] [Related]
2. Arachidonic acid-induced platelet aggregation and thromboxane A2 generation in patients with coronary heart disease.
Szczeklik A; Gryglewski RJ; Musiał J; Grodzínska L; Serwónska M; Wójcik-Switek L; Marcinkiewicz E
Acta Biol Med Ger; 1978; 37(5-6):741-2. PubMed ID: 742286
[TBL] [Abstract][Full Text] [Related]
3. [Synthesis of thromboxane A2: limiting stages of primary thrombocyte aggregation in humans initiated by arachidonic acid and its metabolic products].
Mevkh AT; Basevich VV; Varfolomeev SD
Biokhimiia; 1984 Dec; 49(12):2035-40. PubMed ID: 6441604
[TBL] [Abstract][Full Text] [Related]
4. SIN-1, the main metabolite of molsidomine, inhibits prostaglandin endoperoxide analogue- and arachidonic acid-induced platelet aggregation as well as platelet thromboxane A2 formation.
Block HU; Förster W; Heinroth I
Arzneimittelforschung; 1982; 32(3):189-94. PubMed ID: 6896278
[TBL] [Abstract][Full Text] [Related]
5. Increased platelet prostaglandin and thromboxane synthesis in diabetes mellitus.
Halushka PV; Rogers RC; Loadholt CB; Wohltman H; Mayfield R; McCoy S; Colwell JA
Horm Metab Res Suppl; 1981; 11():7-11. PubMed ID: 7033097
[TBL] [Abstract][Full Text] [Related]
6. Residual cyclooxygenase-1 activity and epinephrine reduce the antiplatelet effect of aspirin in patients with acute myocardial infarction.
Moscardó A; Santos MT; Fuset MP; Ruano M; Vallés J
Thromb Haemost; 2011 Apr; 105(4):663-9. PubMed ID: 21301784
[TBL] [Abstract][Full Text] [Related]
7. Increased platelet thromboxane synthesis in diabetes mellitus.
Halushka PV; Rogers RC; Loadholt CB; Colwell JA
J Lab Clin Med; 1981 Jan; 97(1):87-96. PubMed ID: 7452084
[TBL] [Abstract][Full Text] [Related]
8. [Thrombocyte interaction with a collagen substrate: the role of thrombocyte-synthesized prostaglandin endoperoxides and thromboxane A2].
Mazurov AB; Leĭtin VL; Repin VS
Biull Eksp Biol Med; 1984 Nov; 98(11):563-6. PubMed ID: 6439262
[TBL] [Abstract][Full Text] [Related]
9. Arachidonic acid-induced platelet aggregation is mediated by a thromboxane A2/prostaglandin H2 receptor interaction.
Parise LV; Venton DL; Le Breton GC
J Pharmacol Exp Ther; 1984 Jan; 228(1):240-4. PubMed ID: 6319669
[TBL] [Abstract][Full Text] [Related]
10. Reduced blood platelet sensitivity to aspirin in coronary artery disease: are dyslipidaemia and inflammatory states possible factors predisposing to sub-optimal platelet response to aspirin?
Markuszewski L; Rosiak M; Golanski J; Rysz J; Spychalska M; Watala C
Basic Clin Pharmacol Toxicol; 2006 May; 98(5):503-9. PubMed ID: 16635110
[TBL] [Abstract][Full Text] [Related]
11. [The modification of the biosynthesis and effect of thromboxane A2 and prostacyclin by trapidil (Rocornal)].
Block HU; Heinroth I; Giessler C; Pönicke K; Mentz P; Zehl U; Rettkowski W; Dunemann A; Förster W
Biomed Biochim Acta; 1983; 42(2-3):283-99. PubMed ID: 6411078
[TBL] [Abstract][Full Text] [Related]
12. Thromboxane biosynthesis in platelets of diabetic and coronary artery diseased patients.
Butkus A; Shirey EK; Schumacher OP
Artery; 1982; 11(3):238-51. PubMed ID: 7184495
[TBL] [Abstract][Full Text] [Related]
13. Acetyl glycerylphosphorylcholine aggregates human platelets through two distinct pathways, both dependent on arachidonic acid metabolism.
Macconi D; Morzenti G; Livio M; Morelli C; Cassina G; Remuzzi G
Lab Invest; 1985 Feb; 52(2):159-68. PubMed ID: 3155816
[TBL] [Abstract][Full Text] [Related]
14. Influence of trapidil derivatives on arachidonic acid- and prostaglandin endoperoxide analogue- induced platelet aggregation and thromboxane A2 formation.
Heinroth I; Block HU; Mest HJ
Biomed Biochim Acta; 1984; 43(8-9):S389-92. PubMed ID: 6440555
[TBL] [Abstract][Full Text] [Related]
15. Influence of selective thromboxane synthetase blocker CGS-13080 on thromboxane and prostacyclin biosynthesis in whole blood: evidence for synthesis of prostacyclin by leukocytes from platelet-derived endoperoxides.
Mehta J; Mehta P; Lawson DL; Ostrowski N; Brigmon L
J Lab Clin Med; 1985 Sep; 106(3):246-52. PubMed ID: 3928780
[TBL] [Abstract][Full Text] [Related]
16. Castration reduces platelet thromboxane A2 receptor density and aggregability.
Ajayi AA; Halushka PV
QJM; 2005 May; 98(5):349-56. PubMed ID: 15820970
[TBL] [Abstract][Full Text] [Related]
17. Platelet hyperactivity in acute myocardial infarction in man--effects of prostacyclin.
Mueller HS; Rao PS; Greenberg MA; Buttrick PM; Sussman II; Levite HA; Grose RM; Perez-Davila V; Strain JE; Spaet TH
Herz; 1986 Apr; 11(2):116-26. PubMed ID: 2939012
[TBL] [Abstract][Full Text] [Related]
18. Platelet aggregation induced by arachidonic acid and thromboxane generation in patients with hypertension or cerebrovascular disease.
Matsumoto M; Kusunoki M; Uyama O; Fujisawa A; Matsuyama T; Yoneda S; Kimura K; Abe H
Prostaglandins Med; 1981 Dec; 7(6):553-62. PubMed ID: 7323212
[TBL] [Abstract][Full Text] [Related]
19. Aggregation and inhibition of rat platelets, and the formation of endoperoxide metabolites.
Hwang DH
Prostaglandins Med; 1980 Sep; 5(3):163-73. PubMed ID: 7413850
[TBL] [Abstract][Full Text] [Related]
20. Platelet aggregability, thromboxane A2 and malonaldehyde formation following administration of aspirin to man.
Szczeklik A; Gryglewski RJ; Grodzińska L; Musiał J; Serwońska M; Marcinkiewicz E
Thromb Res; 1979; 15(3-4):405-13. PubMed ID: 494154
[No Abstract] [Full Text] [Related]
[Next] [New Search]
